World Prescription Dermatological Drugs Market 2017: New Biologics and Their Uses in Dermatology / Movement Towards Dispensing Prescription Dermatology Agents / Growth in Platelet Rich Plasma

Dublin, Aug. 25, 2017 -- The "World Prescription Dermatological Drugs Market, 10th Edition" report has been added to Research and Markets' offering.

The field of dermatology is currently experiencing a busy and interesting period and, as a result, the range of therapeutic options available to physicians has expanded. World Prescription Dermatological Drugs Market takes an inclusive look at many different areas of dermatology and prescription dermatology products. This area of medicine has blossomed due to an increase in skin cancer incidence, new exciting biologics for psoriasis, increased demand by baby boomers -both men and women - for antiaging products, consolidation within the industry, and strong late stage pipeline entities.

The worldwide opportunity for prescription dermatology products is dominated by several key markets, including the United States, Europe, Japan, and rest of world. Penetration within any of the prescription dermatological drugs segments is based on the incidence and prevalence in different regions. Level of demand may be based on any number of factors including epidemiology (i.e., skin color), economic conditions, reimbursement issues, and availability of generic products.

There are numerous issues that are shaping the direction of the field of dermatology. Advancements in technology and knowledge of the disease process are influencing the research and development efforts of the industry, along with the decisions of what products to pursue.

Demand in the prescription dermatology products market will likely remain high due to the aging population and the quest for lifestyle treatments to meet the needs of aging baby boomers. There are a number of companies participating in the worldwide market for prescription dermatological drugs, ranging from large international pharmaceutical companies, small niche pharmaceutical companies, to generic companies both large and small. There is also competitive pressure in this market from over-the-counter (OTC) participants. However, even with the availability of OTC products, manufacturers of prescription products continue to do well in terms of revenues.

This is an exciting time in dermatology as there continues to be a shift in the understanding of the pathophysiology of many skin diseases. Some of the most exciting new developments in dermatology include:

• New biologics and their uses in dermatology
• Movement towards dispensing prescription dermatology agents in the office
• Growth in platelet rich plasma

Key Topics Covered:

1: Executive Summary

• Introduction
• Scope And Methodology
• Size And GROWth Of The Market
• Issues And Trends Affecting The Market
• Competitive Outlook

2: Introduction And Overview

• Structure And Function Of The Skin
• Epidermis
• Dermis
• Subcutaneous Tissue
• Epidermal Appendages
• Functions Of The Skin
• Effects Of Aging On The Skin
• Dermatological Conditions And Treatment
• Pharmacokinetics
• Drug Absorption
• Distribution
• Bioavailability
• Drug Delivery Methods
• Demographics Of Skin Disorders, Incidence And Prevalence

3: Issues And Trends

• Introduction
• New Therapeutic Era On Horizon For Atopic Dermatitis
• New Guidelines For Rosacea Treatment
• Patient Compliance
• Cosmetics Dermatologists
• Sunscreen Use
• Melanoma Survival Rates Falter
• New Melanoma Staging System
• Indoor Tanning Issue
• Phosphatidylglycerol And Psoriasis
• New Filler Options
• Consumer Confusion
• Genetic Link To Psoriasis
• Biologic Dermatology
• Rx-To-Otc Switches
• Cosmeceuticals
• Antioxidants
• Polypeptides
• Teledermatology
• Reimbursement Issues
• Market Shift Towards Less Invasive Procedures
• Medi-Spas
• Combination Therapies
• Competitive, Economic, Social Forces Driving Market Demand
• Society'S Obsession With Physical Appearance
• Male Aesthetic GROWth
• Regulatory Influences: Us & International
• International Authorities
• U.S. Fda & Other Regulatory Agencies
• Effects Of Health Insurance Programs & Treatment Costs
• Competitive Influences - Impact On Market & Treatment Modalities
• Facial Skin--Bio-Physiology
• The Gray Areas Of Medicine
• Laser Therapy
• NarROWband Ultraviolet B
• Photodynamic Therapy
• Pycr1 Gene
• Changes In Credit Card Terms
• Patient Protection And Affordable Care Act
• Thermage
• Braf Gene
• New Oral Medications And Research For Acne
• Synthetic Lipids For Skin Healing
• Importance Of Drug Delivery
• Platelet Rich Plasma In Dermatology
• Industry Consolidation

4: Prescription Antiacne And Rosacea Drugs

• Description Of Disorders
• Product Description
• Benzoyl Peroxide
• Retinoids
• Antibiotics
• Oral Contraceptives
• Research And Development
• Market Size And GROWth
• Worldwide Market
• Markets By Geographical Region
• The Future Of The Market
• Competitive Analysis

5: Prescription Antiaging And Photodamage Drugs

• Overview
• Product Description
• Keratolytics
• Moisturizers
• Retinoids
• Sunscreens
• Botox And Fillers
• Research And Development
• Market Forecast And GROWth
• Worldwide Market
• Markets By Geographical Region
• Future Of The Market
• Competitive Analysis

6: Prescription Dermatitis And Seborrhea Drugs

• Overview
• Description Of Products
• Topical Corticosteroids
• Systemic Corticosteroids
• Other Products
• Research And Development
• Market Forecast And Growth
• Worldwide Market By Type
• Markets By Geographical Region
• Future Of The Market
• Competitive Analysis

7: Prescription Antifungal Drugs

• Overview
• Product Description
• Systemic Formulations
• Topical Formulations
• Allylamines And Benzylamines
• Other Topical Formulations
• Novel Products
• Research And Development
• Market Size And Growth
• Worldwide Market By Type
• Markets By Geographical Region
• Future Of The Market
• Competitive Analysis
• The Worldwide Market For Prescription Dermatological Drugs

8: Prescription Hair Loss And Hair Removal Drugs

• Overview
• Product Description
• Antiandrogens
• Androgen Inhibitors
• Other Treatments
• Research And Development
  Market Forecast And GROWth
• Worldwide Market By Type
• Markets By Geographical Region
• Future Of The Market
• Competitive Analysis

9: Prescription Hyperpigmentation/Melasma And Depigmenting Drugs

• Overview
• Product Description
• Research And Development
• Market Forecast And GROWth
• Worldwide Market
• Markets By Geographical Region
• The Worldwide Market For Prescription Dermatological Drugs
• Future Of The Market
• Competitive Analysis

10: Prescription Psoriasis Drugs

• Overview
• Product Description
• Selected Topical Psoriasis Products
• Methoxsalen
• Selected Systemic Psoriasis Preparations
• Light Therapy
• Biologics
• Novel Products
• Research And Development
• Market Forecast And GROWth
• Worldwide Market By Type
• Markets By Geographical Region
• Future Of The Market
• Competitive Analysis

11: Prescription Skin Cancer Drugs

• Overview
• Nonmelanoma Skin Cancers
• Malignant Melanoma
• Product Description

5. Fluorouracil

• Mechlorethamine/Nitrogen Mustard
• Carmustine/Bcnu (Topical)
• Vinblastine (Intralesional) And Others
• Research And Development
• Market Size And GROWth
• Worldwide Market
• Markets By Geographical Region
• Future Of The Market
• Competitive Analysi

12: Miscellaneous Skin Disorder Drugs

• Overview
• Antivirals
• Antiparasitics
• Others
• Product Description
• Antivirals Current Suppliers
• Current Suppliers
• Other Skin Related Products
• Research And Development
• Market Size And GROWth
• Worldwide Market
• Markets By Geographical Region
• Future Of The Market
• Competitive Analysis

13: World Market Summary

• Overview
• Market Size And GROWth
• Market Analysis By Geographical Region
• United States
• Europe
• Japan
• Rest Of World
• Market And Competitive Analysis
  

Companies Mentioned

• AbbVie, Inc.
• Allergan
• Almirall, S.A.
• Amgen, Inc.
• Anacor Pharmaceuticals, Inc.
• Astellas Pharma, Inc.
• Basilea Pharmaceutica Ltd.
• Bayer
• Biofrontera AG
• Bristol-Myers Squibb
• Cipher Pharmaceuticals
• Cutanea Life Sciences
• Dermira, Inc.
• Galderma S.A.
• Genentech
• GlaxoSmithKline Plc
• Johnson & Johnson
• LEO Pharma A/S
• Maruho Co. Ltd.
• Merck & Company
• Merz Pharma GmbH & Co KGaA
• Mylan N.V.
• Novan, Inc.
• Novartis Pharmaceuticals Corporation
• Pfizer, Inc.
• PharmaDerm
• Sienna Biopharmaceuticals, Inc.
• Sinclair Pharma Plc.
• Stiefel
• Valeant Pharmaceuticals International

For more information about this report visit https://www.researchandmarkets.com/research/hpsr9w/world

CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]
         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900
         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716
         Related Topics: Dermatological Drugs